A report by the National Academy of Sciences, Engineering, and Medicine recommends that HHS and other federal agencies form an independent organization that would rely on complex adaptive sysytems to direct cancer control in the U.S.
In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.
